|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to PRWeb Archives
PRWeb: 11-13-2004
Weaver Law Group, a Chicago based regulatory law firm, today unveiled its new client-focused web site. This site was designed to deliver vital information to visitors and clients, providing an improved interface and easy-to-use navigational tools. [PRWEB Nov 12, 2004]
OMNI Technologies, Inc. (OTI) An established supplier of Engineered Systems, Automation/Process Technology, Skid/Cart Fabrication and Instrumentation Services, today announced that it has been awarded a second phase for the complete Design and Build of the USP Pure Water Final Rinse Systems for this Pharmaceutical company; bringing the total project to over $2.2 million in revenues for OMNI Technologies, Inc. [PRWEB Nov 12, 2004]
- IntraLearn Software Corporation, the leading supplier of turnkey e-Learning software applications, announced today that partner Train for Compliance has launched two important new healthcare compliance and practice training websites: Train for Patient Safety and Train for Pharma. Train for Compliance now offers approximately 100 healthcare compliance and practice courses through its affiliated websites. Train for Compliance uses the IntraLearn LSP e-Learning platform for delivery for all of its online courses. [PRWEB Nov 11, 2004]
Pharmachem Laboratories Inc. announces its collaboration with Vitamin Angel Alliance, a charitable organization, to provide multi-vitamins for impoverished and malnourished children in Tibet. Together with Pharmachem and other partners, the Alliance recently sent more than 645,000 multi-vitamin tablets to Tibet, and will continue to ship this same quantity on a monthly basis. [PRWEB Nov 10, 2004]
Research and Markets (researchandmarkets.com/reports/c8787) has announced the addition of OTC Distribution in Europe - the New 2005 Edition to their offering. [PRWEB Nov 10, 2004]
Research and Markets (researchandmarkets.com/reports/c8902) has announced the addition of Post-Genomic Biomarkers: Revolutionizing Drug Development and Diagnostics to their offering. [PRWEB Nov 10, 2004]
Research and Markets (http://www.researchandmarkets.com/reports/c8929) has announced the addition of Post-Genomic Target Validation: Next-Generation Approaches and Tools for Optimizing Target Selection to their offering [PRWEB Nov 10, 2004]
New Web-enabled laboratory productivity solution manages all data types, enables research collaboration and enhances workflow [PRWEB Nov 9, 2004]
TCM LingZhi Peptide is a natural alternative to the flu vaccine for people in high-risk demographics. The nutritional supplement boosts the immune system and increases energy, increasing protection against the flu virus. [PRWEB Nov 9, 2004]
“Regulations passed in 1962 are responsible for over 80% of today’s drug prices” says research scientist Dr. Mary J. Ruwart, Senior Instructor with Sci-Com, Burnet, TX and Adjunct Associate Professor of Biology at the University of North Carolina in Charlotte. [PRWEB Nov 9, 2004]
Heritage Consulting Group, headquarted in Cleveland, Ohio is a group focused on helping clients and members manage their presciption drug spending. 10in10Biz, a two year old company based in California, has provided consumers and participating members innovative ways to save on their drug prescription purchases and work in a team environment to build successful home-based businesses. [PRWEB Nov 9, 2004]
Xtalks presents a speacial web conference on Anti-counterfeiting Drug Strategies featuring Dr. Eshetu Wondemagegnehu, the WHO's expert on counterfeit drugs and Dr. Peter Rost a physician and pharmaceutical industry executive. The event will be held December 10, 2004, 11:00 AM EST, online at xtalks.com. The event is free, but space is limited. Register at www.xtalks.com/dec_who.ashx [PRWEB Nov 9, 2004]
SpectraDigital Corporation, has begun a Phase I clinical pilot of its HIV SpectraPoint™ diagnostic system with AIDS ReSearch Alliance of America (ARA). Up to 40 patients will receive a standard phenotype test as well as the antiviral efficacy test generated by the new HIV SpectraPoint assay. The system could allow physicians to receive results within 24 hours, allowing essential treatment decisions to be made before the virus can develop new, unseen resistance patterns. [PRWEB Nov 9, 2004]
Xtalks (xtalks.com) has launched a new web-based information network to provide business managers with insight into breaking business issues through interactive digital presentations. Starting with a web conference on Anti-Counterfeiting Drug Strategies on December 10, 2004, Xtalks launches a series of interactive web conferences including such topics as Pharmaceutical Compliance and RFID. In 2005, Xtalks will roll out a full slate of monthly and weekly conferences across a range of industry sectors and subject matter. [PRWEB Nov 8, 2004]
Ariadne Genomics, Inc. today announced the release of PathwayAssist™ 3.0, desktop software for visualization and analysis of biological pathways. The new software includes a database of 500,000+ molecular interactions for pathway data mining, significantly improved visualization tools, and wizards for data import and export. [PRWEB Nov 8, 2004]
Research and Markets (researchandmarkets.com/reports/c8715) has announced the addition of Israel Pharmaceutical Country Intelligence Report 2004 to their offering. [PRWEB Nov 6, 2004]
Research and Markets (researchandmarkets.com/reports/c8726) has announced the addition of Israel Outlook Pharmaceutical Country Intelligence Report 2004 to their offering. [PRWEB Nov 6, 2004]
Research and Markets (researchandmarkets.com/reports/c8735) has announced the addition of Costa Rica Outlook Pharmaceutical Country Intelligence Report to their offering. [PRWEB Nov 6, 2004]
Research and Markets (researchandmarkets.com/reports/c8632) has announced the addition of A Guide to Evaluating and Choosing CROs to their offering. [PRWEB Nov 5, 2004]
Research and Markets (researchandmarkets.com/reports/c8619) has announced the addition of Choosing The Proper Long-Term Manufacturing Strategy - System Comparison to their offering. [PRWEB Nov 5, 2004]
Research and Markets (researchandmarkets.com/reports/c8681) has announced the addition of Russia Pharmaceutical Country Intelligence Report 2004 to their offering. [PRWEB Nov 5, 2004]
Constance Lake First Nation has united with various local and regional organizations to make a No Tolernace stand against the illegal sale of prescription drugs in the community. [PRWEB Nov 5, 2004]
Achieving Success with Pay-Per-Call [PRWEB Nov 4, 2004]
Can American consumers order prescriptions drugs safely from Canadian pharmacies and save up to 90%? [PRWEB Nov 4, 2004]
Canadian Company Provides System To Assure Safety of Drugs Imported to U.S. [PRWEB Nov 4, 2004]
First European patent awarded for uses of CCR5 chemokine receptor, a crucial target for novel AIDS therapy - Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key European patent (0 883 687B1) in the area of HIV infection. The patent claims screening methods using the human CCR5 receptor to single out compounds as well as antibodies which can be used in the treatment and/or prevention of HIV infection. Such antibodies are also protected by claims section. [PRWEB Nov 4, 2004]
An October 1 article by crisis management consultant Jonathan Bernstein foreshadowed recent revelations of hidden Merck documents acknowledging the company's awareness of Vioxx's health risks. In the article, he warned Merck execs that a "worldwide jury" was watching them. [PRWEB Nov 4, 2004]
Research and Markets (researchandmarkets.com/reports/c8588) has announced the addition of A Guide to Pharmacovigilance in the EU. to their offering. [PRWEB Nov 4, 2004]
Research and Markets (researchandmarkets.com/reports/c8580) has announced the addition of A Guide to Successful Pharmaceutical Patent Writing to their offering. [PRWEB Nov 4, 2004]
Baxa Ltd. has launched the CyTwo-Fer Needle, featuring a unique hub design that provides vented access to vials or non-vented access to IV bags, performing the work of two devices. Both bags and vials may then be accessed in one procedure - avoiding the expense and time involved in changing needles. Designed to prevent environmental contamination during cytotoxic drug reconstitution, the CyTwo-Fer Needle has a 0.2 micron vent filter, allowing safe and efficient vial reconstitution, aspiration and subsequent injection of drugs into bags or other IV delivery devices. [PRWEB Nov 3, 2004]
|
|
